Treatment

Our August Treatment Roundup

Treating a dog with diabetes for a child with Type 1 reminds Dr. Levetan why she first decided to become an endocrinologist.

The ADA calls for better blood glucose control in its first-ever Type 1 diabetes position paper.

A research team member gives us a peek into the University of Virginia’s artificial pancreas program.

A look back at the diabetes home care devices available in the seventies. (Hint: We have it good now!)

A new study finds ¼ of new Type 1 cases are only discovered when children are suffering from diabetic ketoacidosis.

The latest Type 1 diabetes tech news.

Medical students get their first look at how complicated treating diabetes can be with a first-day class exam.

Hypoglycemia is hard enough without EMTs guilt-tripping you for it.

Our latest Type 1 treatment roundup.

By volunteering to undergo an experimental islet therapy transplant, Chris Stiehl possibly shaved years off the research timeline.

To achieve insulin independence, it’s vitally important to understand why Type 1 diabetes cures for mice don’t work for humans.

How a late-night idea saved the lives of thousands with diabetes and still inspires diabetes researchers today.

In her new book, diabetes educator Ginger Vieira provides ideas to improve communication between people with diabetes and doctors.

Our latest treatment roundup examines the new Type 1 diabetes therapies and the market forces behind them.

But will the FDA’s pulmonary concerns and Exubera’s track record keep this inhalable insulin from getting serious air in the marketplace.

Type 1 diabetes research has had a lot of dead ends over the years, but Dr. Levetan hopes each research effort can lead to greater T1D understanding.

Modern formulas of insulin have helped curb allergy reactions, but not eliminated them. Here’s what you need to know.